The chemists of the “Metal complexes and MRI” research group have developed novel imaging probes which specifically recognise amyloid aggregates, characteristic of Alzheimer’s Disease and Diabetes and gained new insights into their peptide binding mechanisms. These results could facilitate early diagnosis and better molecular understanding of these diseases.
A lire aussi
July 1, 2022 - Seminar of Dr. Julie Menetrey
22 June 2022
par Isabelle Frapart
Mariano Gago prize awarded to the collaboration between the group of Eva Jakab Toth and the University of Coimbra, Portugal
22 June 2022
par Isabelle Frapart
June 24, 2022 - Seminar of Prof. Mariusz Kaczmarek
17 June 2022
par Isabelle Frapart